These studies demonstrate that ICOS is induced on both CD4 and CD8 T cells in the peripheral blood and the tumor following tumor radiation and demonstrated that targeting this pathway with a novel ICOS agonist antibody can enhance immune mediated local control following radiation. This evidence concerns the gene CD8A and neoplasm.